65
Participants
Start Date
January 10, 2005
Primary Completion Date
January 24, 2008
Study Completion Date
January 24, 2008
teduglutide 0.05 mg/kg/d
0.05 mg/kg/d subcutaneous injection
teduglutide 0.10 mg/kg/d
0.10 mg/kg/d subcutaneous injection
Hôpital Erasme, Brussels
Rigshospitalet, Copenhagen
Albany Medical Center, Albany
University of Rochester Medical Center, Rochester
University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania - Penn Nursing, Philadelphia
Emory University Hospital, Atlanta
The Cleveland Clinic Foundation, Cleveland
Hôpital Huriez, Lille
University of Nebraska Medical Center, Omaha
Hôpital de la Croix-Rousse, Lyon
Mayo Clinic Scottsdale, Scottsdale
Hôpital Lariboisière, Paris
Rhode Island Hospital, Providence
St. Paul's Hospital, Vancouver
St. Michael's Hospital, Toronto
Toronto General Hospital, Toronto
Academic Medical Center, Department of Endocrinology & Metabolism, Amsterdam
Pracownia Żywienia, Olsztyn
Samodzielny Publiczny Szpital Kliniczny-Im.prof W.Orłowskiego CMKP, Warsaw
St. Mark's Hospital, Harrow
Lead Sponsor
Shire
INDUSTRY